ARS Pharma Insider Trades Signal Growth: Buy‑Low, Sell‑High Tactics Boost Long‑Term Stake
INSIDER TRADING IN ARS PHARMACEUTICALS: CCO Eric Karas’ balanced buy‑sell strategy highlights short‑term gains and long‑term confidence in the ImmunoTAC platform, while market buzz and valuation cautions shape investor insight.
3 minutes to read